Wissenschaftliche Arbeiten

Doç. Dr. Doğan Yazılıtaş

101 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Quantifying the Survival Benefit of Trimodality Therapy in Esophageal Squamous Cell Carcinoma: An IPTW-adjusted Retrospective Analysis

    Acta haematologica oncologica Turcica., 2026

    DOI 10.4274/ahot.galenos.2026.2026-4-6 Frei zugänglicher VolltextQuelle: OpenAlex

  2. Real-world outcomes of ribociclib treatment in HR-positive/HER2-negative metastatic breast cancer: efficacy, safety, and prognostic factors

    Expert review of anticancer therapy, 2026

    DOI 10.1080/14737140.2026.2733826 PMID 42733172 Quelle: Europe PMC

  3. Real-world outcomes of ribociclib treatment in HR-positive/HER2-negative metastatic breast cancer: efficacy, safety, and prognostic factors

    Figshare, 2026

    DOI 10.6084/m9.figshare.33717648 Frei zugänglicher VolltextQuelle: OpenAlex

  4. Prognostic Role of Nutritional and Inflammatory Indices in Predicting Adverse Clinical Outcomes in Unplanned Hospitalized Oncology Patients

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15082992 PMID 42074794 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  5. Prognostic value of pan-immune-inflammation index in hepatocellular carcinoma compared with albumin-bilirubin and model for end-stage liver disease sodium

    World Journal of Gastrointestinal Oncology, 2026

    DOI 10.4251/wjgo.121250 Frei zugänglicher VolltextQuelle: OpenAlex

  6. Fear of Cancer Recurrence and Psychological Symptom Burden in Breast Cancer Survivors Without Evidence of Active Disease: A Cross-Sectional Real-World Study

    Healthcare (Basel, Switzerland), 2026

    DOI 10.3390/healthcare14162665 PMID 42651434 Frei zugänglicher VolltextQuelle: Europe PMC

  7. Evaluation of definitively treated early and locally advanced malignant salivary gland tumors

    Asian Journal of Surgery, 2026

    DOI 10.1016/j.asjsur.2025.09.131 Frei zugänglicher VolltextQuelle: ORCID

  8. 159eP Prognostic value of the immune checkpoint inhibitor score (IChIS) in palliative immunotherapy-treated non-small cell lung cancer: A real-world study

    ESMO Open, 2026

    DOI 10.1016/j.esmoop.2026.106466 Frei zugänglicher VolltextQuelle: OpenAlex

  9. Mean platelet volume-to-albumin ratio as a predictor of pathological complete response in HER2-positive breast cancer undergoing neoadjuvant chemotherapy

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-04938-w PMID 41979751 Frei zugänglicher VolltextQuelle: OpenAlex

  10. Real-World Evaluation of the Immune Checkpoint Inhibitor Score (IChIS) in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15197750 PMID 42882209 Frei zugänglicher VolltextQuelle: OpenAlex

  11. Effect of chemoradiation followed by surgery on outcomes compared to definitive chemoradiation in locally advanced esophageal squamous cell carcinoma: A single-center experience.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.e16129 Quelle: OpenAlex

  12. BMI and PNI as predictors of treatment completion and survival in locally advanced HNSCC receiving sequential chemoradiotherapy

    BMC cancer, 2025

    DOI 10.1186/s12885-025-15240-3 PMID 41398663 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  13. Prognostic Significance of Dynamic Inflammatory Indices in Head and Neck Cancer During Induction Chemotherapy

    Journal of Oncological Sciences, 2025

    DOI 10.37047/jos.galenos.2025.2025-11-3 Frei zugänglicher VolltextQuelle: OpenAlex

  14. Assessment of malnutrition in cancer patients: a geriatric approach with the mini nutritional assessment

    Frontiers in Nutrition, 2025

    DOI 10.3389/fnut.2025.1590137 PMID 40416373 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  15. The unseen struggle—depression and associated factors in geriatric cancer patients

    Frontiers in Medicine, 2025

    DOI 10.3389/fmed.2025.1603515 PMID 40776912 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  16. Low HALP Score Predicts Prolonged Hospitalization in Solid Tumor Patients with Febrile Neutropenia

    Current Oncology, 2025

    DOI 10.3390/curroncol33010014 PMID 41590334 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  17. BMI and PNI as Predictors of Treatment Completion and Survival in Locally Advanced HNSCC Receiving Sequential Chemoradiotherapy

    Research Square, 2025

    DOI 10.21203/rs.3.rs-7560992/v1 Frei zugänglicher VolltextQuelle: ORCID

  18. STAT3 Expression in Organ-Preserved Laryngeal Carcinomas: Correlation with Treatment Resistance and Conventional Parameters

    Head and Neck Pathology, 2025

    DOI 10.1007/s12105-024-01748-w PMID 39907870 Frei zugänglicher VolltextQuelle: ORCID

  19. Treatment Outcomes and Prognostic Factors Affecting Survival in Thymic Carcinoma

    Acta haematologica oncologica Turcica., 2025

    DOI 10.4274/ahot.galenos.2025.2025-11-5 Frei zugänglicher VolltextQuelle: OpenAlex

  20. Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)

    European Archives of Oto-Rhino-Laryngology, 2024

    DOI 10.1007/s00405-024-08744-4 PMID 38795147 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  21. Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG).

    Journal of Clinical Oncology, 2024

    DOI 10.1200/jco.2024.42.16_suppl.e18004 Quelle: ORCID

  22. Analyzing HALP and PNI scores as prognostic factors in metastatic head and neck cancers

    Asian Journal of Surgery, 2024

    DOI 10.1016/j.asjsur.2024.04.093 PMID 38704268 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  23. The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker

    Breast Cancer: Targets and Therapy, 2024

    DOI 10.2147/bctt.s464161 PMID 38974895 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  24. Metastatic diffuse follicular variant papillary thyroid cancer without cervical lymph node metastasis presenting with symptoms related to hypopituitarism

    Einstein (Sao Paulo, Brazil), 2023

    DOI 10.31744/einstein_journal/2023rc0229 PMID 37493833 Frei zugänglicher VolltextQuelle: ORCID

  25. Percutaneous ablation treatment in metastatic lung tumors: a single-center experience

    Acta Radiologica, 2023

    DOI 10.1177/02841851231175657 PMID 37246396 1 Zitation (Europe PMC) Quelle: ORCID

  26. The Incidental Diagnosis of Lung Cancer Through Chest Tomography During the COVID-19 Pandemic

    Journal of Oncological Sciences, 2023

    DOI 10.37047/jos.2023-98748 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  27. Outcomes of Chemotherapy plus Cetuximab as First-line Treatment in Patients with Metastatic, Recurrent, Unresectable Head and Neck Cancers: Real-life Data

    Journal of College of Physicians And Surgeons Pakistan, 2023

    DOI 10.29271/jcpsp.2023.04.469 PMID 37190724 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  28. Sunitinib Versus Pazopanib as Initial Therapy for Metastatic Renal Cell Carcinoma of Intermediate and Poor-Risk Characteristics: Real-World, a Single-Center

    Journal of Cancer Treatment and Research, 2023

    DOI 10.11648/j.jctr.20231101.11 Frei zugänglicher VolltextQuelle: OpenAlex

  29. Erken evre mide kanserli hastalarda iskelet kas dansitesinin sağkalım üzerine etkisi

    Turkish Journal of Clinics and Laboratory, 2022

    DOI 10.18663/tjcl.1078240 Frei zugänglicher VolltextQuelle: OpenAlex

  30. P84.03 GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients

    Journal of Thoracic Oncology, 2021

    DOI 10.1016/j.jtho.2021.01.1202 Frei zugänglicher VolltextQuelle: OpenAlex

  31. GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

    Lung Cancer, 2020

    DOI 10.1016/j.lungcan.2020.07.022 PMID 32799090 30 Zitationen (Europe PMC) Quelle: OpenAlex

  32. Predictors of Neoplasia in Colonic Wall Thickening Detected via Computerized Tomography.

    Cureus, 2020

    DOI 10.7759/cureus.10553 PMID 32968607 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  33. The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study.

    PubMed, 2019

    PMID 31424664 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  34. P1.14-15 Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

    Journal of Thoracic Oncology, 2019

    DOI 10.1016/j.jtho.2019.08.1166 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  35. A new prognostic index in patients with hormone receptor-positive and HER2-negative breast cancer,Nowy wskaźnik prognostyczny u pacjentek z rakiem piersi i ekspresja receptorów hormonalnych oraz brakiem ekspresji HER2

    Current Gynecologic Oncology, 2019

    DOI 10.15557/cgo.2019.0020 Frei zugänglicher VolltextQuelle: ORCID

  36. Investigation of the severity of depressive symptoms in cancer patients receiving chemotherapy

    Eastern Journal of Medicine, 2019

    DOI 10.5505/ejm.2019.02419 Frei zugänglicher VolltextQuelle: ORCID

  37. Investigation of Clinical Features and the Use of Complementary and Alternative Medicines in Cancer Patients, A Single-Center Experience.

    Acta Oncologica Turcica, 2019

    DOI 10.5505/aot.2019.85579 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  38. Local treatment options for management of loco-regional esophageal squamous cell carcinoma

    Romanian Journal of Military Medicine, 2019

    DOI 10.55453/rjmm.2019.122.2.7 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  39. "Squamos cell lung cancer" case applying with dyspepsia complaints

    Journal of Oncological Sciences, 2018

    DOI 10.1016/j.jons.2018.08.001 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  40. The relationship between localization and neutrophil lymphocyte ratio in colon carcinoma

    Ortadoğu Tıp Dergisi, 2018

    DOI 10.21601/ortadogutipdergisi.398756 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  41. Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study

    Asia-Pacific Journal of Clinical Oncology, 2018

    DOI 10.1111/ajco.12685 PMID 28429422 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  42. Çoklu Primer Tümörler-Tek Merkez Deneyimi

    Dicle Medical Journal / Dicle Tip Dergisi, 2017

    DOI 10.5798/dicletip.362337 Frei zugänglicher VolltextQuelle: OpenAlex

  43. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection

    Clinical Colorectal Cancer, 2017

    DOI 10.1016/j.clcc.2016.08.002 PMID 27670893 20 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  44. Queries for the article entitled "Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases"

    The Breast, 2017

    DOI 10.1016/j.breast.2016.06.009 PMID 27368144 Quelle: ORCID

  45. The real life outcomes of modified docetaxel and cisplatin plus fluorourasil regimen in patients with metastatic gastric cancer.

    Journal of Clinical Oncology, 2016

    DOI 10.1200/jco.2016.34.15_suppl.e15548 Quelle: OpenAlex

  46. Biological Subtypes and Distant Relapse Pattern in Breast Cancer Patients After Curative Surgery (Study of Anatolian Society of Medical Oncology)

    Breast Care, 2016

    DOI 10.1159/000448186 PMID 27721711 15 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  47. Dosetaxel Induced Pericardial Effusion in Two Gastric Cancer Patients

    UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, 2016

    DOI 10.4999/uhod.161140 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  48. Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO)

    Journal of B.U.ON., 2016

    PMID 27273958 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  49. Squamous Cell Cancer of The Lung with Synchronous Renal Cell Carcinoma

    Turkish Thoracic Journal/Türk Toraks Dergisi, 2016

    DOI 10.5578/ttj.30510 PMID 29404140 Frei zugänglicher VolltextQuelle: ORCID

  50. The clinical and pathological features affecting the time of relapse in patients with early stage colorectal cancer

    Journal of Cancer Research and Therapeutics, 2016

    DOI 10.4103/0973-1482.199527 PMID 28169236 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID